CVS Saying ‘No’ to Tobacco Celebrated at State of the Union

By Sheryl Estrada


Merlo

The national spotlight that shined on CVS Health when the company first announced in February 2014 that it would end tobacco sales is about to get brighter.

President and CEO Larry J. Merlo will be a guest at Tuesday’s State of the Union address for his company’s efforts in making a difference in the health of Americans. He will join 22 others in a box with First Lady Michelle Obama; Dr. Jill Biden, wife of Vice President Joe Biden; and Valerie Jarrett, Senior Advisor to the President.

“It’s certainly exciting, and I think it’s really a recognition that reflects the work of our more than 200,000 colleagues across the country,” Merlo told the Providence Journal. “I think everyone could relate to the effects of tobacco and how it may have affected a family member or a loved one.”

The White House also highlighted CVS Health’s recruitment and talent-development efforts, saying in a release that Merlo “has prioritized the company’s commitment to creating economic opportunities for current and future colleagues at all levels. CVS Health recognizes the value of military service and has a long-standing commitment to hiring qualified veterans and military spouses. The company has also established programs to hire long-term unemployed workers, create summer jobs for youth and transition workers off public assistance. CVS Health also trains pharmacy technicians through apprenticeship programs, offers scholarships to future pharmacists, and engages diverse students interested in science, technology, engineering and math (STEM) careers.”

CVS Health (one of DiversityInc’s 25 Noteworthy Companies) is the first major pharmacy chain in the U.S. to stop selling tobacco products—most notably, cigarettes. The recent rebranding of the company, from CVS Caremark to CVS Health, involves multiple initiatives to foster wellness in its customers as well as its employees.

On Sept. 3, a month before its original deadline of Oct. 1, CVS stores nationwide ceased sales of tobacco products. It was a risky decision, which could result in the loss of approximately $2 billion in sales.

In a statement in September, Merlo said, “Selling tobacco in a healthcare setting was becoming a growing contradiction for the health brand. By eliminating cigarettes and tobacco products from sale in our stores, we can make a difference in the health of all Americans.”

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Latest News

Humana Announces New Care Coordination Services for Members with Kidney Disease

Originally posted on Humana.com Designed To Improve the Patient Experience and Health Outcomes, Services to be Available Initially in Four States Leading health and well-being company Humana Inc. (NYSE: HUM) Monogram Health and Somatus, Humana will offer care coordination to better diagnose and manage kidney disease toward improving members’ quality of life and…

Mastercard and Doconomy Extend Collaboration to Deliver a More Sustainable Future

Originally published on Mastercard.com. S&P Global Joins Effort to Power Global Platform Available to All Issuers Further Support Provided by Mastercard Investment in Doconomy Madrid COP25, December 10, 2019 – Doconomy and Mastercard today extended their joint effort to combat climate change. Moving beyond previously announced programs, this new arrangement brings the ability…

As Change Accelerates, Insurers Need Profound Transformation and the Right Talent, Reveals EY Insurance Outlook 2020

Originally posted on EY.com Declining interest rates, changing customer expectations and shifting demographics are defining the future of insurance Insurers must strike the right balance between achieving operational excellence and investing in technology-led innovation As insurance industry growth remains stagnant for another year due to low interest rates, the shifts…

Accenture Named a Leader in Automated Life Insurance Underwriting Systems by Independent Research Firm

Originally posted on Accenture.com Accenture has been named a leader in automated life insurance underwriting systems in a new report from independent research firm Forrester. In the report — “The Forrester Wave™: Automated Life Insurance Underwriting Systems, Q4 2019”[1] — Accenture was named a leader based on the current offering and…

AbbVie and Scripps Research Announce Collaboration to Develop a Broad Range of New Therapeutics

Originally posted on Abbvie.com AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, today announced a collaboration to develop new therapies for a range of diseases, including in the therapeutic areas of oncology, immunology, neurology, and fibrosis. “Based on our…